Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Leases (2020 - 2025)

Historic Leases for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $2.3 million.

  • Insight Molecular Diagnostics' Leases fell 2202.6% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 2202.6%. This contributed to the annual value of $2.8 million for FY2024, which is 6841.78% up from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Leases stood at $2.3 million, which was down 2202.6% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Leases registered a high of $4.0 million during Q2 2023, and its lowest value of $537000.0 during Q2 2021.
  • Moreover, its 5-year median value for Leases was $2.6 million (2024), whereas its average is $2.7 million.
  • Its Leases has fluctuated over the past 5 years, first crashed by 8419.19% in 2021, then surged by 55158.29% in 2022.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Leases stood at $3.5 million in 2021, then tumbled by 37.73% to $2.2 million in 2022, then dropped by 24.87% to $1.6 million in 2023, then skyrocketed by 68.42% to $2.8 million in 2024, then fell by 15.13% to $2.3 million in 2025.
  • Its Leases stands at $2.3 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.6 million for Q1 2025.